Aditya Birla SL Multi Asset Omni FOF
The scheme seeks to generate capital appreciation primarily from a portfolio of active and passive schemes of equity, debt and commodities based schemes accessed through diversified investment styles.
Growthvine rating: 4/5 — ranked #9 of 55 in category.
Fund basics
| Category | Hybrid: Multi Asset |
|---|
| NAV | ₹72.85 (as of 2026-10-21) |
|---|
| AUM | ₹478 Cr |
|---|
| Expense ratio | 1.14% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Kartikeya Singh |
|---|
| Exit load | 1% for redemption within 365 days |
|---|
Performance & risk
| 5-year annualised return | 11.65% |
|---|
| Sharpe ratio | 0.78 |
|---|
| Standard deviation | 11.33% |
|---|
| Max drawdown | −22.75% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 122.8% of NIFTY Multi Asset - Equity : Debt : Arbitrage : REITs/InvITs (50:20:20:10) Index's upside and 82.1% of its downside.
Market cap allocation
| Large cap | 45.1% |
|---|
| Mid cap | 25.4% |
|---|
| Small cap | 29.4% |
|---|
Concentration
| Top 5 holdings | 47.6% |
|---|
| Top 10 holdings | 71.1% |
|---|
| Total holdings | 10 |
|---|
Top holdings
- Aditya Birla Sun Life Gold ETF — 12.5%
- Aditya Birla Sun Life Flexi Cap Fund - Growth - Direct Plan — 11.7%
- Aditya Birla Sun Life Small Cap Fund - Growth - Direct Plan — 10.4%
- Aditya Birla Sun Life Multi-Cap Fund-Direct Growth — 9.7%
- Aditya Birla Sun Life Midcap Fund - Growth - Direct Plan — 9.4%
- Aditya Birla Sun Life Short Term Fund - Growth - Direct Plan — 6.6%
- Aditya Birla Sun Life Corporate Bond Fund - Growth - Direct Plan — 6.6%
- Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth — 6.4%
- Aditya Birla Sun Life Consumption Fund - Growth - Direct Plan — 6.3%
- Aditya Birla Sun Life Banking and Financial Services Fund - Direct Plan - Growth — 5.9%
Top sectors
Not disclosed.
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −2.1% | Q2 | #21 of 44 |
| 2025 | 18.2% | Q2 | #15 of 34 |
| 2024 | 16.7% | Q2 | #8 of 23 |
| 2023 | 23.1% | Q2 | #8 of 17 |
| 2022 | 1.3% | Q4 (Bottom) | #12 of 14 |